Compare PTCT & MNSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | MNSO |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.9B |
| IPO Year | 2006 | 2020 |
| Metric | PTCT | MNSO |
|---|---|---|
| Price | $72.40 | $15.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 1 |
| Target Price | ★ $80.65 | $26.20 |
| AVG Volume (30 Days) | ★ 774.1K | 394.9K |
| Earning Date | 05-05-2026 | 05-22-2026 |
| Dividend Yield | N/A | ★ 4.16% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | ★ 7.78 | N/A |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $21.09 |
| Revenue Next Year | $19.02 | $15.43 |
| P/E Ratio | ★ $9.30 | $20.04 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $35.95 | $15.31 |
| 52 Week High | $87.50 | $26.74 |
| Indicator | PTCT | MNSO |
|---|---|---|
| Relative Strength Index (RSI) | 58.99 | 39.63 |
| Support Level | $69.81 | $15.38 |
| Resistance Level | $79.59 | $20.29 |
| Average True Range (ATR) | 2.25 | 0.34 |
| MACD | 0.47 | 0.05 |
| Stochastic Oscillator | 81.77 | 18.87 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
MINISO Group Holding Ltd is a value retailer offering a variety of trendy lifestyle products featuring IP design. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying, and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying, and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.